The National Company NUCLEARELECTRICA S.A. is seeking to purchase two sets of Startup Instrumentation (SUI) for Units 1 and 2 at the Cernavodă Nuclear Power Plant. Suppliers have 20 days to request clarifications before the bid submission deadline. The contracting entity will only respond to clarifi
Tender closed on 27 Jan 2026. Awaiting award.
This procurement opportunity involves the acquisition of domestic and/or international air transport services. The services include the booking and issuance of airline tickets necessary for the business travel of SNN personnel. This will be conducted under a framework agreement lasting 48 months. Su
This contract involves the procurement of two sets of Startup Instrumentation (SUI) for Units 1 and 2 at the Cernavodă Nuclear Power Plant. Suppliers have 20 days to request clarifications before the bid submission deadline. The contracting authority will only respond to clarification requests made
This procurement opportunity is for Owner Controlled Insurance Program (OCIP) services for the project 'Modernization of Unit 1 at the Cernavodă Nuclear Power Plant'. The insurance policies will be effective from May 31, 2026, at 18:31, until the operational handover of Unit 1, expected in June 2030
This contract involves the provision of specialized recruitment and selection services for workforce through a framework agreement lasting 48 months. Suppliers have 20 days to request clarifications before the deadline for submitting offers. The contracting authority will respond clearly and complet
UK-based astronomy observers can apply for travel and subsistence grants of up to £15,000 over two years to visit facilities with competitively awarded observation time.
UK biomedical researchers can apply for up to £1 million in MRC funding to purchase a single piece of mid-range capital equipment by 31 December 2027.
NERC invites qualified researchers to apply for large grants (£1.12-£3.45 million) for innovative environmental science projects lasting up to five years.
UKRI is offering up to £60 million over seven years for a director-led research institute to investigate obesity and cardiometabolic disease mechanisms with translation to prevention and treatment strategies.
